Peter Suzman

Peter Suzman

Creator
0 followers

Biotech investor/entrepreneur; small-cap biotech analysis

ABVX Analysis Solid; Cancers Likely Unrelated to Drug Timing
SocialJun 3, 2026

ABVX Analysis Solid; Cancers Likely Unrelated to Drug Timing

I think this is a good $ABVX analysis. Apart from the fact that the timing of these cancers are very likely too soon for them to be drug-related. (No position myself).

By Peter Suzman
FDA Eyes PR Win with Rapid RVMD Approval
SocialMay 30, 2026

FDA Eyes PR Win with Rapid RVMD Approval

The FDA desperately needs a publicity win. Expect the $RVMD drug to be approved in record time.

By Peter Suzman
Non‑CD20 MS Drugs Cause Irreversible Damage, CD20 Better
SocialMay 28, 2026

Non‑CD20 MS Drugs Cause Irreversible Damage, CD20 Better

Just re-upping this important $TGTX thread from a while ago - bottom line here, MS patients on the weaker (non-CD20) drugs like teriflunomide (Aubagio) suffer ongoing, irrecoverable damage. There are some larger ongoing trials comparing CD20 drugs to others that...

By Peter Suzman
Brilliant Scientists, Dark Legacies: Fact Meets Fiction
SocialMay 23, 2026

Brilliant Scientists, Dark Legacies: Fact Meets Fiction

I recently listened (on Spotify) to a fascinating book by Benjamin Labatut (“When we Cease to Understand the World”) that is a history of famous 20th Century scientists that mostly ended up falling off the edge in some way. Starts...

By Peter Suzman
Lower Short Rates Could Steepen Curve; TIPS Safest
SocialMay 19, 2026

Lower Short Rates Could Steepen Curve; TIPS Safest

I suspect that any reduction in short rates would serve to exacerbate this weakness. Yield curve would simply steepen further. TIPS may be the only safe haven here.

By Peter Suzman
Long‑term PPI Users Should Monitor Minerals to Prevent Dementia
SocialMay 14, 2026

Long‑term PPI Users Should Monitor Minerals to Prevent Dementia

If you are a long-term user of PPI's (like Prilosec or Nexium) routinely check magnesium, calcium, ferritin, Vitamin B12, zinc, and copper levels. B12 or copper deficiencies could absolutely contribute to accelerated dementia.

By Peter Suzman
Geopolitics Accelerate Global Shift to Solar‑Battery Power
SocialMay 14, 2026

Geopolitics Accelerate Global Shift to Solar‑Battery Power

Trump and the Iran war are, somewhat paradoxically, accelerating the worldwide transition to renewables - mainly the solar + battery route. Here Cuba. Pakistan is another example, where DIY solar+battery competes very well with a sclerotic fossil-fuel-powered utility system.

By Peter Suzman
Ensitrelvir Outperforms Paxlovid yet Faces Approval Hurdles
SocialMay 14, 2026

Ensitrelvir Outperforms Paxlovid yet Faces Approval Hurdles

Ensitrelvir is pretty clearly also a better acute treatment than Paxlovid. More potent and many fewer drug-drug interactions. Just proved too hard to get approval for acute treatment.

By Peter Suzman
LQDA’s Soaring Market Share Proves Drug Superiority
SocialMay 11, 2026

LQDA’s Soaring Market Share Proves Drug Superiority

$LQDA "Market share has gone from 10% to 16% to 23% across past 3 quarters" That doesn't happen against an entrenched competitor unless the drug is truly better.

By Peter Suzman
Andes Hantavirus Low Transmissibility, Unlikely Pandemic Risk
SocialMay 11, 2026

Andes Hantavirus Low Transmissibility, Unlikely Pandemic Risk

So Andes hantavirus is infectious, but not very infectious. PCR positive a few days before symptoms. This does not have the makings of a widespread pandemic.

By Peter Suzman
Underpowered Trial Misleads: Non‑significant Trend, Not Failure
SocialMay 10, 2026

Underpowered Trial Misleads: Non‑significant Trend, Not Failure

One of my pet peeves is a headline saying "This trial showed drug X doesn't work in condition Y" when in actuality what was demonstrated was a non-significant trend to efficacy in a severely underpowered trial.

By Peter Suzman
MANE Secures Patent, Launches Trials to Address Minoxidil
SocialMay 10, 2026

MANE Secures Patent, Launches Trials to Address Minoxidil

Turns out I was dead wrong in this thread from some four years back. $MANE managed to get a patent (US 12,268,688 ) and is conducting full-scale trials to assuage the obvious safety concerns with the approved Minoxidil oral dose.

By Peter Suzman
Economics Will Outpace Trump's Coal Push, Solar Wins
SocialMay 9, 2026

Economics Will Outpace Trump's Coal Push, Solar Wins

Meanwhile Trump is pushing coal. But the economics will win - a few year delay for the US before solar plus batteries dominate.

By Peter Suzman
Hospital Samples Create False Negative Correlation Between Independent Diseases
SocialMay 9, 2026

Hospital Samples Create False Negative Correlation Between Independent Diseases

Berkson’s paradox or Berkson bias: If you look at only hospitalized patients, you will typically see a negative correlation between any two independent conditions (A and B) that each would lead to hospitalization. Intuitively, among hospitalized patients, if someone does not...

By Peter Suzman
Peter Suzman | Pulse